The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3,4-dichlorophenoxy)-2,5-difluoro-N-(methylsulfonyl)benzamide ID: ALA4537339
PubChem CID: 117760464
Max Phase: Preclinical
Molecular Formula: C14H9Cl2F2NO4S
Molecular Weight: 396.20
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CS(=O)(=O)NC(=O)c1cc(F)c(Oc2ccc(Cl)c(Cl)c2)cc1F
Standard InChI: InChI=1S/C14H9Cl2F2NO4S/c1-24(21,22)19-14(20)8-5-12(18)13(6-11(8)17)23-7-2-3-9(15)10(16)4-7/h2-6H,1H3,(H,19,20)
Standard InChI Key: KASGDBJYKOICKB-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
3.6526 -1.7045 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4450 -1.9192 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.2347 -1.1256 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0403 -4.3748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0392 -5.1944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7472 -5.6033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4569 -5.1939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4541 -4.3712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7455 -3.9660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7470 -6.4205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0392 -6.8289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3351 -6.4171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6277 -6.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6271 -7.6429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3397 -8.0515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0441 -7.6414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3312 -5.6024 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.1602 -3.9600 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.3424 -8.8687 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.9198 -8.0523 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.7430 -3.1488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4495 -2.7381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0341 -2.7423 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1536 -1.5102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
6 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 1 0
8 18 1 0
15 19 1 0
14 20 1 0
9 21 1 0
21 22 1 0
21 23 2 0
22 2 1 0
2 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 396.20Molecular Weight (Monoisotopic): 394.9597AlogP: 3.75#Rotatable Bonds: 4Polar Surface Area: 72.47Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.00CX Basic pKa: ┄CX LogP: 3.30CX LogD: 2.36Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.85Np Likeness Score: -1.48
References 1. DiMauro EF, Altmann S, Berry LM, Bregman H, Chakka N, Chu-Moyer M, Bojic EF, Foti RS, Fremeau R, Gao H, Gunaydin H, Guzman-Perez A, Hall BE, Huang H, Jarosh M, Kornecook T, Lee J, Ligutti J, Liu D, Moyer BD, Ortuno D, Rose PE, Schenkel LB, Taborn K, Wang J, Wang Y, Yu V, Weiss MM.. (2016) Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors., 59 (17): [PMID:27441383 ] [10.1021/acs.jmedchem.6b00425 ]